כסף מזומן למניה nasuspharma.com (NSRX)

Nasus Pharma Ltd. - לוגו גרפי של המנפיק NSRX

Nasus Pharma Ltd (NSRX) attracts scientists through R&D freedom and stock options, creating innovative powder formulations. This has resulted in partnerships with pharmacies to implement nasal sprays. This chart of cash per share visualizes this progress, where 0.35 captures the current value of the indicator. The financial model relies on a virtual format, fully delegating drug production to certified contract manufacturing organizations.

Nasus Pharma, Ltd. (NSRX) - מזומנים למניה מ-14.08.2025 עד 20.11.2026

פילוחים אנליטיים של חברת Nasus Pharma Ltd

- שער מניה ותחזית מחירי מומחים:
- מדדי זמינות כספים ותזרימי מזומנים:
ניתוח מסכם של החברה:NSRX, Nasus Pharma, Ltd.
סחורת הדגל של Nasus Pharma Ltd

This metric is calculated as the ratio of total cash to the number of shares outstanding, depending on the efficiency of operational management. The metric determines the business's actual liquid foundation by filtering out informational noise. For Nasus Pharma Ltd (NSRX), this is a critical resource for developing intranasal drug delivery technologies. By analyzing fluctuations in cash per share, an investor assesses the balance between financial security and the speed of implementing medical innovations.